2007
DOI: 10.1038/nbt1295
|View full text |Cite
|
Sign up to set email alerts
|

A human phenome-interactome network of protein complexes implicated in genetic disorders

Abstract: We performed a systematic, large-scale analysis of human protein complexes comprising gene products implicated in many different categories of human disease to create a phenome-interactome network. This was done by integrating quality-controlled interactions of human proteins with a validated, computationally derived phenotype similarity score, permitting identification of previously unknown complexes likely to be associated with disease. Using a phenomic ranking of protein complexes linked to human disease, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
808
0
9

Year Published

2010
2010
2017
2017

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 840 publications
(826 citation statements)
references
References 54 publications
9
808
0
9
Order By: Relevance
“…Network analysis Protein-protein interaction (PPI) networks were created for each list of differentially expressed proteins and first-order neighbours using InWeb [21]. The networks were visualised in Cytoscape [22].…”
Section: Methodsmentioning
confidence: 99%
“…Network analysis Protein-protein interaction (PPI) networks were created for each list of differentially expressed proteins and first-order neighbours using InWeb [21]. The networks were visualised in Cytoscape [22].…”
Section: Methodsmentioning
confidence: 99%
“…Effective utilization of these large-scale data has been validated useful in analyzing individual disease proteins or related complexes. For example, Lage et al prioritized disease proteins based on a systematic analysis of human protein complexes comprising gene products implicated in many different categories of human disease [26]. Vanunu et al provided a global network-based method for prioritizing disease proteins and inferring protein complex associations with a disease of interest [27].…”
Section: Introductionmentioning
confidence: 99%
“…In which, the problem is considered as a classification one, where a classifier is learned from training data; then the learned classifier is used to predict whether or not a test/candidate gene is a disease gene. Briefly, at the early, machine learningbased studies usually approached disease gene prediction as a binary classification problem [9], where the learning samples are comprised of positive training samples and negative training samples [9] such as decision trees (DT) [10,11] k-nearest neighbor (kNN) [12], naive Bayesian classifier [13,14], binary support vector machine classifier [15][16][17], artificial neural network (ANN) techniques [18] and random forest (RF) [9]. In these binary classifier-based methods, positive training samples are constructed from known disease genes, whereas negative training samples are the remaining which are not known to be associated with diseases.…”
Section: Introductionmentioning
confidence: 99%